A. Taylor Kelley
No Rating Available
(Learn About Our Rating System)

A. Taylor Kelley, MD, MPH, MS

Languages spoken: English, Spanish

A. Taylor Kelley, MD, MPH, MSc, is an assistant professor in the Division of General Internal Medicine and a primary care and addiction medicine physician in the VA Salt Lake City Health Care System. As a clinician investigator and health services researcher, his research interests include healthcare quality and access for individuals experiencing socioeconomic disadvantage, with focus on behavioral health and primary care for immigrant, tribal, and veteran populations. His current work is funded by the National Institutes of Health, U.S. Department of Veterans Affairs, and Utah Department of Health and Human Services.

Dr. Kelley received his undergraduate degree in economics from Brigham Young University and his medical degree from the University of Texas McGovern Medical School at Houston. He completed residency training in internal medicine and pediatrics at Yale-New Haven Hospital and a health services research fellowship in the National Clinician Scholars Program at the University of Michigan. He holds a master of public health degree from Harvard and master of science degree in health care research from the University of Michigan. He is a board certified by the American Board of Internal Medicine and American Board of Preventive Medicine (Addiction Medicine).

Specialties

Board Certification

American Board of Internal Medicine
National Board of Medical Examiners
American Board of Preventive Medicine (Addiction Medicine)

A. Taylor Kelley, MD, MPH, MSc, is an assistant professor in the Division of General Internal Medicine and a primary care and addiction medicine physician in the VA Salt Lake City Health Care System. As a clinician investigator and health services researcher, his research interests include healthcare quality and access for individuals experiencing socioeconomic disadvantage, with focus on behavioral health and primary care for immigrant, tribal, and veteran populations. His current work is funded by the National Institutes of Health, U.S. Department of Veterans Affairs, and Utah Department of Health and Human Services.

Dr. Kelley received his undergraduate degree in economics from Brigham Young University and his medical degree from the University of Texas McGovern Medical School at Houston. He completed residency training in internal medicine and pediatrics at Yale-New Haven Hospital and a health services research fellowship in the National Clinician Scholars Program at the University of Michigan. He holds a master of public health degree from Harvard and master of science degree in health care research from the University of Michigan. He is a board certified by the American Board of Internal Medicine and American Board of Preventive Medicine (Addiction Medicine).

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor
Academic Divisions General Medicine
Board Certification
American Board of Internal Medicine
National Board of Medical Examiners
American Board of Preventive Medicine (Addiction Medicine)

Education history

Undergraduate Major: Economics; Minor: Music - Brigham Young University B.A.
Professional Medical Medicine - McGovern Medical School at the University of Texas Health Science Center at Houston M.D.
Graduate Training Health Policy and Management - Harvard T.H. Chan School of Public Health M.P.H.
Internship/Residency Internal Medicine and Pediatrics - Yale New Haven Hospital Intern/Resident
Graduate Training Health and Health Care Research - University of Michigan M.S.
Postdoctoral Fellowship VA Scholar, National Clinician Scholars Program - VA Ann Arbor Healthcare System/University of Michigan Postdoctoral Scholar
Professional Other Quality Improvement - Intermountain Health Certification

Selected Publications

Journal Article

  1. Kelley AT, Turner J, Doolittle (2018). Barriers to Advance Care Planning in End-Stage Renal Disease: Who is to Blame, and What Can be Done?. The New bioethics, 24(2), 150-157.
  2. Incze MA, Kelley AT, Johnson (2022). Reexamining Medicaid Patient Review and Restriction Programs Amid the Evolving Opioid Epidemic. JAMA internal medicine,
  3. Incze MA, Kelley AT, Gordon A (2022). Champions Among Us: Leading Primary Care to the Forefront of Opioid Use Disorder Treatment. Journal of general internal medicine, 37(7), 1771-1773.
  4. Kelley AT, Smid MC, Baylis JD, Charron E, Begaye LJ, Binns-Calvey A, Archer S, Weiner S, Pettey W, Cochran (2022). Treatment access for opioid use disorder in pregnancy among rural and American Indian communities. Journal of substance abuse treatment, 136, 108685.
  5. Radmall AO, Calder S, Codell N, Kelley AT, Hawkins E, Jones AL, Hagedorn HJ, Reynolds MA, Gordon A (2022). Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative. Journal of addictions nursing, 33(2), 70-79.
  6. Jones AL, Kelley AT, Suo Y, Baylis JD, Codell NK, West NA, Gordon A (2022). Trends in Health Service Utilization After Enrollment in an Interdisciplinary Primary Care Clinic for Veterans with Addiction, Social Determinants of Health, or Other Vulnerabilities. Journal of general internal medicine, 38(1), 12-20.
  7. Williams AR, Johnson KA, Thomas CP, Reif S, Socías EM, Henry BF, Neighbors C, Gordon AJ, Horgan C, Nosyk B, Drexler K, Krawczyk N, Gonsalves GS, Hadland SE, Stein BD, Fishman M, Kelley AT, Pincus HA, Olfson (2022). Opioid use disorder Cascade of care framework design: A roadmap. Substance abuse, 43(1), 1207-1214.
  8. Baylis JD, Charron E, Archer S, Garets M, Bryan MA, Foringer J, Kelley AT, Smid MC, Cochran (2022). Attitudes, self-efficacy, and practices related to opioid risk assessment and mitigation: A comparison of health care professionals in rural communities. Substance abuse, 43(1), 1163-1171.
  9. Incze MA, Kelley AT, Singer P (2021). Heterogeneous State Cannabis Policies: Potential Implications for Patients and Health Care Professionals. JAMA, 326(23), 2363-2364.
  10. Kelley AT, Dungan MT, Gordon A (2021). Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19. Journal of addiction medicine, 15(5), 439-440.
  11. Incze MA, Kelley AT, Gordon A (2021). Improving Opioid Use Disorder Treatment through Quality Assessment. Journal of general internal medicine, 36(9), 2820-2822.
  12. Kelley AT, Smid MC, Baylis JD, Charron E, Binns-Calvey AE, Archer S, Weiner SJ, Begaye LJ, Cochran (2021). Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addiction science & clinical practice, 16(1), 40.
  13. Gordon SH, Beilstein-Wedel E, Rosen AK, Zheng T, Kelley AT, Cook J, Zahakos SS, Wagner TH, Vanneman M (2021). County-level Predictors of Growth in Community-based Primary Care Use Among Veterans. Medical care, 59(Suppl 3), S301-S306.
  14. Codell N, Kelley AT, Jones AL, Dungan MT, Valentino N, Holtey AI, Knight TJ, Butz A, Gallop C, Erickson S, Patton J, Hyte-Richins LJ, Rollins BZ, Gordon A (2021). Aims, development, and early results of an interdisciplinary primary care initiative to address patient vulnerabilities. The American journal of drug and alcohol abuse, 47(2), 160-169.
  15. Yu M, Kelley AT, Morgan AU, Duong A, Mahajan A, Gipson J (2020). Challenges for Adult Undocumented Immigrants in Accessing Primary Care: A Qualitative Study of Health Care Workers in Los Angeles County. Health equity, 4(1), 366-374.
  16. Kelley AT, Greenstone CL, Kirsh S (2020). Defining Access and the Role of Community Care in the Veterans Health Administration. Journal of general internal medicine, 35(5), 1584-1585.
  17. Kelley AT, Tipirneni R, Levy (2019). Changes in Veterans' Coverage and Access to Care Following the Affordable Care Act, 2011-2017. American journal of public health, 109(9), 1233-1235.
  18. Incze MA, Kelley AT, Singer P (2023). Implementing the White House's Strategic Plan to Save Lives Amid the Opioid Crisis: Reaching for the "North Star". JAMA, 329(9), 705-706.
  19. Vanneman ME, Rosen AK, Wagner TH, Shwartz M, Gordon SH, Greenberg G, Zheng T, Cook J, Beilstein-Wedel E, Greene T, Kelley A (2023). Differences Between VHA-Delivered and VHA-Purchased Behavioral Health Care in Service and Patient Characteristics. Psychiatric services (Washington, D.C.), 74(2), 148-157.
  20. Kelley AT, Wilcox J, Baylis JD, Crossnohere NL, Magel J, Jones AL, Gordon AJ, Bridges JF (2022). Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives. Journal of general internal medicine,
  21. Percy A, Kelley AT, Valentino N, Butz A, Baylis JD, Suo Y, Gordon AJ, Jones A (2023). Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders. Substance abuse, 44(4), 330-336.
  22. Kelley AT, Incze MA, Baumgartner M, Campbell ANC, Nunes EV, Scharfstein D (2024). Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders. Drug and alcohol dependence, 261, 111368.
  23. Kelley AT, Torre MP, Wagner TH, Rosen AK, Shwartz M, Lu CC, Brown TK, Zheng T, Beilstein-Wedel E, Vanneman M (2024). Trends in Bundled Outpatient Behavioral Health Services in VA-Direct Versus VA-Purchased Care. Administration and policy in mental health, 51(6), 998-1010.
  24. Hafen K, Wallace H, Fritz K, Fordham C, Haskell T, Kelley AT, Jones AL, Cochran G, Gordon A (2024). A novel rural hospital/clinic-system practice-based research network: the Rural Addiction Implementation Network (RAIN) initiative and its goals, implementation, and early results. The American journal of drug and alcohol abuse, 1-12.
  25. Merrill RM, Kelley AT, Cox E, Layman AB, Layton BJ, Lindsay (2010). Factors and barriers influencing influenza vaccination among students at Brigham Young University. Medical science monitor, 16(2), PH29-34.
  26. Kelley AT, Tipirneni (2018). Care for Undocumented Immigrants - Rethinking State Flexibility in Medicaid Waivers. The New England journal of medicine, 378(18), 1661-1663.
  27. Kelley AT, Yoo M, Suo Y, Nelson RE, Gordon AJ, Jones A (2025). Changes in healthcare utilization and costs following enrollment in an interprofessional primary care clinic designed to address clinical and social vulnerabilities. Journal of interprofessional care, 1-11.
  28. Incze MA, Huebler S, Baylis JD, Stofko A, Kelley AT, Binswanger IA, Gordon A (2025). Mortality Among Veterans With Opioid Use Disorder After Medical Hospitalization. JAMA internal medicine, 185(6), 734-736.

Review

  1. Kelley AT, Incze MA, Baylis JD, Calder SG, Weiner SJ, Zickmund SL, Jones AL, Vanneman ME, Conroy MB, Gordon AJ, Bridges JF (2022). Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Substance abuse, 43(1), 1286-1299.
  2. Incze MA, Kelley AT, James H, Nolan S, Stofko A, Fordham C, Gordon A (2024). Post-hospitalization Care Transition Strategies for Patients with Substance Use Disorders: A Narrative Review and Taxonomy. Journal of general internal medicine, 39(5), 837-846.
  3. Franks L, Cochran G, Reeves C, Incze MA, Hardy CJ, Gordon AJ, Kelley A (2024). Evaluations of State Medical Cannabis Programs in the USA: A Narrative Review. Medical cannabis and cannabinoids, 7(1), 243-256.

Editorial

  1. Kelley AT, Weiner SJ, Francis (2023). Directly Observed Care: Crossing the Chasm of Quality Measurement. Journal of general internal medicine, 38(1), 203-207.

Letter

  1. Kelley AT, Incze M (2023). The need for a more inclusive and objective approach in developing a core outcomes set for opioid use disorder. Addiction (Abingdon, England), 118(1), 194-195.
  2. Incze MA, Kelley T, Singer P (2023). The White House's Strategic Plan to Address the Opioid Crisis-Reply. JAMA, 329(24), 2195.